Quick links
Categories
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Roadmap: Revision of the EU general pharmaceuticals legislation
As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the Commission plans to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and crisis-resistant medicines regulatory system.
All
This is some text inside of a div block.
This is some text inside of a div block.
Roadmap: Revision of the EU general pharmaceuticals legislation
As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the Commission plans to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and crisis-resistant medicines regulatory system.
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
July 6, 2020
PPTA feedback to the EU Pharmaceutical Strategy Inception Impact Assessment
The Plasma Protein Therapeutics Association (PPTA) welcomes the Commission’s initiative to help ensure EU’s supply of safe and affordable medicines to meet patients’ needs and reinforce EU’s pharmaceutical industry competitiveness.
All
This is some text inside of a div block.
This is some text inside of a div block.
July 6, 2020
PPTA feedback to the EU Pharmaceutical Strategy Inception Impact Assessment
The Plasma Protein Therapeutics Association (PPTA) welcomes the Commission’s initiative to help ensure EU’s supply of safe and affordable medicines to meet patients’ needs and reinforce EU’s pharmaceutical industry competitiveness.
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
PPTA position paper on the importance of the EU-US MRA for patient access to plasma-derived medicinal products (PDMPs)
All
This is some text inside of a div block.
This is some text inside of a div block.
PPTA position paper on the importance of the EU-US MRA for patient access to plasma-derived medicinal products (PDMPs)
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
August 1, 2022
PPTA position paper on Stockpiling: EU needs effective measures to facilitate access to lifesaving medicines made of human plasma (PDMPs)
All
This is some text inside of a div block.
This is some text inside of a div block.
August 1, 2022
PPTA position paper on Stockpiling: EU needs effective measures to facilitate access to lifesaving medicines made of human plasma (PDMPs)
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
No results found